文献速递重症综合管理与镇静镇痛

临床衰弱量表与医院衰弱风险评分预测危重患者长期生存能力的比较:多中心回顾性队列研究

Comparison of the predictive ability of clinical frailty scale and hospital frailty risk score to determine long-term survival in critically ill patients: a multicentre retrospective cohort study.
PubMed 文献 · Crit Care · 2022-05-03
一句话结论在16个ICU的7001例患者中,临床衰弱量表(CFS)与医院衰弱风险评分(HFRS)均独立预测1年生存,但CFS区分度更好(AUROC 0.66 vs 0.63,p<0.0001)。

该多中心回顾性队列研究纳入澳大利亚维多利亚州16个公立ICU在2017年1月1日至2018年6月30日期间、登记于澳大利亚和新西兰重症监护学会成人患者数据库且有CFS记录的7001例ICU患者,计算基于ICD-10编码的HFRS。结果显示,HFRS与CFS相关性弱(Spearman's rho 0.13,95%CI 0.10-0.15),一致性差(kappa=0.12,95%CI 0.10-0.15)。校正混杂因素后,CFS(HR 1.26,95%CI 1.21-1.31)和HFRS(HR 1.08,95%CI 1.02-1.15)均独立预测1年生存。CFS对1年死亡的区分度优于HFRS(AUROC 0.66 vs 0.63,p<0.0001)。

要点

  • 在7001例ICU患者中,CFS与HFRS均独立预测1年生存:CFS的HR为1.26(95%CI 1.21-1.31),HFRS的HR为1.08(95%CI 1.02-1.15)。
  • CFS对1年死亡的区分度优于HFRS:AUROC 0.66 vs 0.63(p<0.0001)。
  • HFRS与CFS相关性弱(Spearman's rho 0.13,95%CI 0.10-0.15),一致性差(kappa=0.12,95%CI 0.10-0.15)。
  • 研究队列总体中位年龄63.7岁(IQR 49.1-74.0),男性59.5%(n=4166),中位APACHE II评分14分(IQR 10-20),46.7%(n=3266)接受机械通气。
  • 住院死亡率为9.5%(n=642),1年死亡率为14.4%(n=1005)。

适用人群与场景

  • 澳大利亚维多利亚州16个公立ICU在2017年1月1日至2018年6月30日期间收治、登记于澳大利亚和新西兰重症监护学会成人患者数据库且有CFS记录的ICU患者。

研究设计与关键结果

  • 研究类型:多中心回顾性队列研究,纳入16个公立ICU的7001例ICU患者,均具有CFS和HFRS两种衰弱测量。
  • 人群特征:总体中位年龄63.7岁(IQR 49.1-74.0),男性59.5%(n=4166),中位APACHE II评分14分(IQR 10-20),46.7%(n=3266)接受机械通气。
  • 结局:住院死亡率9.5%(n=642),1年死亡率14.4%(n=1005)。
  • HFRS与CFS相关性弱:Spearman's rho 0.13(95%CI 0.10-0.15),一致性差:kappa=0.12(95%CI 0.10-0.15)。
  • 校正混杂因素(包括性别和入ICU时基线疾病严重程度ANZROD)后,CFS预测1年生存的HR为1.26(95%CI 1.21-1.31),HFRS的HR为1.08(95%CI 1.02-1.15)。
  • CFS对1年死亡的区分度优于HFRS:AUROC 0.66 vs 0.63(p<0.0001)。

证据类型、等级与局限

  • 证据类型:多中心回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,HFRS和CFS均独立预测ICU入院后1年生存,区分度中等;CFS对1年生存的预测优于HFRS。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The Clinical Frailty Scale (CFS) is the most commonly used frailty measure in intensive care unit (ICU) patients. The hospital frailty risk score (HFRS) was recently proposed for the quantification of frailty. We aimed to compare the HFRS with the CFS in critically ill patients in predicting long-term survival up to one year following ICU admission.

METHODS: In this retrospective multicentre cohort study from 16 public ICUs in the state of Victoria, Australia between 1st January 2017 and 30th June 2018, ICU admission episodes listed in the Australian and New Zealand Intensive Care Society Adult Patient Database registry with a documented CFS, which had been linked with the Victorian Admitted Episode Dataset and the Victorian Death Index were examined. The HFRS was calculated for each patient using the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) codes that represented pre-existing conditions at the time of index hospital admission. Descriptive methods, Cox proportional hazards and area under the receiver operating characteristic (AUROC) were used to investigate the association between each frailty score and long-term survival up to 1 year, after adjusting for confounders including sex and baseline severity of illness on admission to ICU (Australia New Zealand risk-of-death, ANZROD).

RESULTS: 7001 ICU patients with both frailty measures were analysed. The overall median (IQR) age was 63.7 (49.1-74.0) years; 59.5% (n = 4166) were male; the median (IQR) APACHE II score 14 (10-20). Almost half (46.7%, n = 3266) were mechanically ventilated. The hospital mortality was 9.5% (n = 642) and 1-year mortality was 14.4% (n = 1005). HFRS correlated weakly with CFS (Spearman's rho 0.13 (95% CI 0.10-0.15) and had a poor agreement (kappa = 0.12, 95% CI 0.10-0.15). Both frailty measures predicted 1-year survival after adjusting for confounders, CFS (HR 1.26, 95% CI 1.21-1.31) and HFRS (HR 1.08, 95% CI 1.02-1.15). The CFS had better discrimination of 1-year mortality than HFRS (AUROC 0.66 vs 0.63 p < 0.0001).

CONCLUSION: Both HFRS and CFS independently predicted up to 1-year survival following an ICU admission with moderate discrimination. The CFS was a better predictor of 1-year survival than the HFRS.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Subramaniam A, Ueno R, Tiruvoipati R, et al. Comparison of the predictive ability of clinical frailty scale and hospital frailty risk score to determine long-term survival in critically ill patients: a multicentre retrospective cohort study. Crit Care. 2022. PMID: 35505435. doi:10.1186/s13054-022-03987-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。